These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 8124743)

  • 1. Timing of onset of menses after GnRH agonist treatment for central precocious puberty.
    Klein KO; Vargas Trujillo M; Dragnic S; Van Komen S; Li M; Lee PA
    J Pediatr Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38898800
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression.
    Pimenta R; Malulf FC; Romão P; Caetano GVB; da Silva KS; Ghazarian V; Dos Santos GA; Guimarães V; Silva IA; de Camargo JA; Recuero S; Melão BVLA; Antunes AA; Srougi M; Nahas W; Leite KRM; Reis ST
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):70. PubMed ID: 38305916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth, development and prediction of body height in children with central precocious puberty after 3 years of therapy with Decapeptyl-Depot, a slow-releasing GnRH agonist].
    Hümmelink R; Oostdijk W; Partsch CJ; Odink RJ; Drop SL; Sippell WG
    Cesk Pediatr; 1994; 49(1):7-12. PubMed ID: 8124755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [D-Trp-6 gonadotropin analog releasing hormone (Decapeptyl-Depot)-- the drug of choice in central idiopathic precocious puberty].
    Hníková O; Janecková M; Finková M
    Cesk Pediatr; 1994; 49(1):22-4. PubMed ID: 8124745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
    Hümmelink R; Oostdijk W; Partsch CJ; Odink RJ; Drop SL; Sippell WG
    Horm Metab Res; 1992 Mar; 24(3):122-6. PubMed ID: 1533604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
    Partsch CJ; Hümmelink R; Sippell WG; Oostdijk W; Odink RJ; Drop SL
    Monatsschr Kinderheilkd; 1993 Dec; 141(12):935-9. PubMed ID: 8114776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ; Hümmelink R; Peter M; Sippell WG; Oostdijk W; Odink RJ; Drop SL
    Horm Res; 1993; 39(3-4):111-7. PubMed ID: 8262471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term therapy of true precocious puberty in girls using Decapetyl-Depot, a superactive gonadoliberin agonist in depot microcapsulated form].
    Sippell WG; Partsch CJ; Hümmelink R; Lorenzen F
    Cesk Pediatr; 1994; 49(1):13-8. PubMed ID: 8124743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of central precocious puberty with sustained-release triptorelin].
    Boucekkine C; Blumberg-Tick J; Roger M; Thomas F; Chaussain JL
    Arch Pediatr; 1994 Dec; 1(12):1127-37. PubMed ID: 7849900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptorelin depot for the treatment of children 2 years and older with central precocious puberty.
    Bertelloni S; Mucaria C; Baroncelli GI; Peroni D
    Expert Rev Clin Pharmacol; 2018 Jul; 11(7):659-667. PubMed ID: 29957076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central precocious puberty: current treatment options.
    Antoniazzi F; Zamboni G
    Paediatr Drugs; 2004; 6(4):211-31. PubMed ID: 15339200
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.